Perioperative fluid therapy and associated outcomes of patients undergoing major elective open gastrointestinal surgery are poorly understood. This study measured perioperative fluid therapy, complication rates and outcomes for major elective open gastrointestinal surgery in a tertiary care hospital. We obtained demographic data, operative details, fluid prescription, complications and outcomes in 100 patients. Patients were elderly and had multiple comorbidities. Median delivered intraoperative fluid volume was 4.2 litres, followed by 6.3 litres over the subsequent 24 hours. Perioperative fluid prescription was associated with a positive fluid balance. Complications occurred in 57% of patients with 32% experiencing at least one major complication. Serious complications were substantially more frequent in patients having non-colorectal operations. The most common adverse events were pulmonary oedema (21%), ileus (18%), serious sepsis (17%), pneumonia (17%), arrhythmias (14%), delirium (14%) and wound healing problems (infections 13%, anastomotic leaks 12%). Mortality at 30 days was 2%. This study provides planning data for future interventional studies.
Major elective open gastrointestinal surgery is common 1 . It typically involves elderly patients with multiple comorbid medical conditions 2 and, apart from oesophagectomy, does not usually include routine postoperative management in intensive care 3 . These demographic and logistic factors potentially expose patients to a high rate of complications and/or unfavourable outcomes. In particular, in several small studies involving specific subgroups of such patients, investigators have linked perioperative complications with perioperative intravenous fluid therapy [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . This link suggests that nonoperative management may be an important determinant of complications, and patient outcome may be amenable to improvement. Yet there is lack of data on current fluid therapy, complications and outcomes. This lack of information makes it very difficult to plan rational and feasible interventions and/or design suitably powered trials to evaluate protective strategies. Accordingly, a greater understanding of perioperative treatment, morbidity and outcomes in major open gastrointestinal surgery is potentially useful.
We hypothesised that similar to the findings of a major randomised controlled study 6 , in a tertiary Australian hospital in patients having major elective gastrointestinal surgery, comorbidities would be present in more than 30% of cases, cancer would represent the reason for surgery in more than 70% of cases, intravenous fluid therapy would be conservative (fluid prescription less than 3l over first 24 hours), the overall complication rate below 50%, the major complication rate less than 25% and mortality similar to or below 5%. We tested our hypotheses by conducting a retrospective observational study.
METHODS
The study was approved by the Austin Health Human Research Ethics Committee. The hospital records of adult patients admitted for major elective open gastrointestinal surgery from January 2005 to July 2006 were retrospectively analysed. Patients undergoing procedures confined to the hepatobiliary tract (e.g. orthotopic liver transplantation, liver resection) were excluded. Demographic preoperative data, information on comorbidities, key biochemical variables, American Society of Anesthesiologists class and type of surgery were recorded. Perioperative fluid administration was obtained from the beginning of fasting to the end of the second postoperative day. We collected data on major and minor complications as previously defined 6 and on 30-day mortality. We used the information obtained to test the following hypotheses: 1. Comorbidities would be present in more than 30% of cases. 2. Cancer would represent the reason for surgery in more than 70% of cases. 3. Intravenous fluid therapy would be conservative (defined as fluid prescription less than 3l over first 24 hours). 4. The overall complication rate would be below 50%. 5. The major complication rate would be less than 25%. 6. The mortality rate would similar to or below 5%.
Additionally, we sought to identify whether particular patients were at increased risk of complications and whether specific perioperative variables were linked with unfavourable outcomes. We tested our hypotheses by first performing a descriptive statistical analysis. We expressed continuous variable as means and standard deviation and compared groups using the Mann-Whitney u test. Categorical variables were compared by the χ 2 test with Yates' correction or Fisher's exact test where appropriate. Multivariate analyses of risk factors for morbidity and mortality were performed using a binary logistic regression model. logistic regression was used for categorical outcome analyses of the following preoperative factors: age, gender, primary diagnosis, comorbidities (cardiorespiratory disease, renal disease, diabetes mellitus), American Society of Anesthesiologists classification and age-adjusted Charlson comorbidity index. All statistical analyses were performed using statistical software. Results were considered significant at P <0.05.
RESulTS
One hundred sequential patient records were evaluated. Patient demographics, baseline clinical characteristics, comorbidities and operative details are summarised in Table 1 . Most patients were elderly, male and overweight, with multiple comorbidities. The majority of operations were for malignancy and were colorectal resections. Details of fluid therapy are provided in Table 2 . The mean volume of fluid administered during surgery was in excess of four litres, with higher volumes given to patients having non-colorectal surgery. On the first postoperative day, the total mean volume of fluid administered across all patients was greater than six litres and overall 48-hour fluid balance was close to 6.5 litres. Blood product administration was similar for both patient groups. Major and minor postoperative complications were common and are summarised in Table 3 . Overall, 57% of patients had at least one complication. Thirty-two percent of patients had at least one major complication and 52% of patients had at least one minor complication. Major and minor complications occurred more than twice as frequently in those undergoing non-colorectal procedures. Hospital length of stay was more than twice as long in the non-colorectal group (30 vs 12 days; P=0.004). Non-colorectal procedures had significantly higher rates of re-operation (mainly due to anastomotic leaks), sepsis, pneumonia and pulmonary congestion. Of all patients studied, 10% of patients had a major cardiac complication, 17% developed postoperative pneumonia and 25% experienced important tissue healing problems. In each category, the incidence was higher in the noncolorectal group. Overall 30 days hospital mortality was 2%, with one death in each of the colorectal and non-colorectal groups. Specific complications and patient outcomes are listed in Table 4 .
univariate analyses showed that age greater than 70 years, non-colorectal surgery, duration of surgery greater than three hours and perioperative blood transfusion were all associated with hospital morbidity. Only prolonged operations (RR of 5.355, P=0.003) and blood administration (RR 3.032, P=0.05) were associated with subsequent adverse outcomes on multivariate analysis.
DISCuSSION
We performed a retrospective study in patients receiving major elective open gastrointestinal surgery. We sought to define their preoperative demographic and clinical features and reason for surgery, measure their perioperative fluid therapy and determine their complication rate and outcome at day 30 after surgery. We found that, as hypothesised, our patients had multiple comorbidities and typically had surgery for cancer. We further found that, in contradiction to our hypothesis, fluid therapy was not conservative, postoperative fluid balance was strongly positive and complication rates were higher than expected. Moreover, prolonged surgery and blood transfusion were independent predictors of hospital morbidity.
The demographic and clinical features of our patients are broadly in keeping with other reports in similar types of surgery, especially colorectal [6] [7] [8] . However, as there are no previous published studies of elective major open gastrointestinal surgery, direct comparisons are not possible. The mean amount of fluid administered to the colorectal patients in our study was more than twice that given to the restrictive arm in the study of colorectal surgery patients by Brandstrup et al 6 . This might appear surprising, given the positive results from several small studies 6, 7, 15, 16 suggesting that a restrictive approach may reduce morbidity in colorectal surgery patients and reviews arguing that large volumes of fluid have the potential to cause harm during the perioperative period 4,17-23 , especially in the absence of guidance from complex physiological monitoring 24 . While there is controversy about the generalisability of such findings and the correctness of such opinions, and no phase III studies have yet been conducted, we hypothesised that such investigations and editorials might have somewhat influenced practice in our institution. They have not. These results reflect the behaviour of over one hundred clinicians (anaesthetists, surgeons, intensivists and trainees) involved in patient care, suggesting that this practice is pervasive.
Over half of all patients experienced at least one complication. In particular, patients having noncolorectal operations (mostly oesophageal, gastric and pancreatic resections) were much more likely to have problems. These adverse events were associated with prolongation of hospital stay. The overall complication rate was slightly higher than hypothesised and seems high in absolute terms: however, it is similar to reports from previous investigators in patients having colorectal surgery where complications rates ranged from 15 16 to 70% 7 . using the same defined list of complications that we studied, Brandstrup found for elective colorectal surgery, 25% of patients had at least one major complication and for elective colorectal surgery, 25% of patients had at least one major complication and 50% had at least one minor complication 6 . In our colorectal patients, their incidence was 21 and 45% respectively, suggesting that in our patients, performance was in keeping with expectations. The complications evaluated are common to most studies of perioperative fluid administration and are also common to other published reviews of abdominal surgical outcomes 25, 26 . While the pattern of specific types of complications in our cohort was also similar to those of Brandstrup, there do appear to be some differences. We found a relatively higher rate of anastomotic leak, severe sepsis, myocardial infarction, ileus, pneumonia and pulmonary congestion, all of which could be plausibly linked to high volumes of fluid therapy. Interestingly, this was not associated with a correspondingly higher number of deaths in our patients. Recent investigations comparing surgery in the elderly in our hospital with that of two other teaching hospitals in Melbourne 27 also confirm a performance level which is indistinguishable from that of similar institutions in our region.
There are several limitations of our study. Only one hundred patient records were reviewed, so for some individual procedures the numbers of patients were relatively small. However, this is the first ever study conducted in patients with major elective open gastrointestinal surgery and is similar in size to other reports of fluid therapy, complications and outcome, published so far. Our study was retrospective and observational in nature, so it is possible that not all complications were properly recorded. However, this would simply reinforce the contention that these patients experience a high level of postoperative complications. There may also have been inaccuracies in the recording of fluid therapy. However, we timed our review of medical records to follow on from the introduction of new comprehensive intraoperative fluid therapy documentation practices and consider this unlikely. In addition, all medical records were reviewed by two investigators to check that a thorough and accurate tally of fluid administration and losses was performed. There was no association between higher volumes of fluid administration and adverse events. However, very few patients received fluid therapy that could be considered 'restrictive', making separation negligible and meaningful assessment impossible. This is a singlecentre study, which limits the external validity of our findings. However, our hospital has all the typical characteristics of a tertiary institution in a developed country and a recent comparative study confirmed that its patients and their outcomes were identical to those of other tertiary hospitals in Australia 27 .
Our study also has several strengths. The collection of data on comorbid conditions to calculate the Charlson comorbidity index provided a comprehensive evaluation of the baseline health characteristics of our patient population. The inclusion of all patients with high predicted anaesthetic and surgical risk and open gastrointestinal surgery make the findings of this study more consistent with the experience of day-to-day clinical practice and encompass groups that have not been yet formally studied. It is also possible that these more complex patients would benefit most from improvements in care 1, 28, 29 . Finally, by defining the complication rate and mortality rate in these patients, we have defined both a need for improved care and the necessary background for the power calculations needed to design interventional trials.
In conclusion, our evaluation of gastrointestinal surgical outcomes in a tertiary referral hospital has identified several important findings. Most patients are older and have important comorbidities. Complications occur frequently, especially in patients having non-colorectal gastrointestinal operations. Intravenous fluid therapy follows a liberal approach, despite earlier studies and several clinical guidelines suggesting benefits associated with a restrictive or net even approach to fluid therapy 30 . The findings specific to non-colorectal operations are of particular interest as the higher rates of complications and prolonged length of stay provide good opportunities to evaluate strategies aimed at improving perioperative care for this group.
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